Most recently, Dr Armstrong was president and CEO of CuraGen, from March 2006 until September 2007. Prior to CuraGen, Mr Armstrong was CEO of Bioaccelerate Holdings, Provensis and Phoqus Pharmaceuticals.
Dr Armstrong has more than 20 years of experience at major pharmaceutical and leading biotechnology companies where he has been integral in bringing new pharmaceutical products to the market.
Mr Jon Court, the current CEO, will work closely with Mr Frank Armstrong and the senior management team at Fulcrum in his new role as director of strategic business development.